RWA Wealth Partners’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

RWA Wealth Partners’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-15,000	Closed	-$13K	–	249
2019 Q4	$13K	Hold	15,000	–	–	﹤0.01%	237
2019 Q3	$8K	Hold	15,000	–	–	﹤0.01%	229
2019 Q2	$8K	Hold	15,000	–	–	﹤0.01%	228
2019 Q1	$7K	Hold	15,000	–	–	﹤0.01%	229
2018 Q4	$7K	Hold	15,000	–	–	﹤0.01%	217
2018 Q3	$8K	Hold	15,000	–	–	﹤0.01%	228
2018 Q2	$8K	Buy	+15,000	New	+$6.99K	﹤0.01%	638

RWA Wealth Partners's GCVRZ Position: Q1 2020 in Review

RWA Wealth Partners sold out of Sanofi Contingent Value Rights (GCVRZ) in Q1 2020, closing a stake of 15,000 shares — an estimated $13K sold.

RWA Wealth Partners first reported a position in GCVRZ in Q2 2018 and held it in 7 quarters. The position peaked at $13K in Q4 2019. 2 funds tracked by Wall St. Rank hold GCVRZ as of Q1 2020.

RWA Wealth Partners reported no remaining Sanofi Contingent Value Rights position as of Q1 2020 after selling out during the quarter.
RWA Wealth Partners sold 15,000 Sanofi Contingent Value Rights shares in Q1 2020, an estimated $13K.
RWA Wealth Partners first reported a position in Sanofi Contingent Value Rights in Q2 2018 and held it in 7 quarters.
RWA Wealth Partners's Sanofi Contingent Value Rights position peaked at $13K in Q4 2019.
2 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q1 2020.

Based on RWA Wealth Partners's 13F filing for Q1 2020, filed 8 Apr 2020.